Jon Congleton, CEO of Mineralys Therapeutics ($MLYS), sold common shares on the open market 12 times in the past year for a total of $10.7 million. His most recent sale occurred on January 12, 2026. Among 11,678 insiders, his sales rank 1,074th by amount, surpassing the average of $8.6 million over 6.4 transactions. Congleton made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 31, 2026 | Mineralys Therapeutics, Inc. | $MLYS | Congleton Jon | Chief Executive Officer | S | Common Stock | 19364 | $25.50 | 760,687.0000 | 79,139,956 | 2.48% | 0.02% |
| March 31, 2026 | Mineralys Therapeutics, Inc. | $MLYS | Congleton Jon | Chief Executive Officer | S | Common Stock | 453 | $27.05 | 705,051.0000 | 79,139,956 | 0.06% | 0.00% |
| March 31, 2026 | Mineralys Therapeutics, Inc. | $MLYS | Congleton Jon | Chief Executive Officer | S | Common Stock | 55183 | $26.54 | 705,504.0000 | 79,139,956 | 7.25% | 0.07% |
| Feb. 19, 2026 | Mineralys Therapeutics, Inc. | $MLYS | Congleton Jon | Chief Executive Officer | A | Stock Option | 187900 | $0.00 | 187,900.0000 | 79,139,956 | 9999.99% | 0.24% |
| Feb. 19, 2026 | Mineralys Therapeutics, Inc. | $MLYS | Congleton Jon | Chief Executive Officer | A | Common Stock | 140900 | $0.00 | 780,051.0000 | 79,139,956 | 22.04% | 0.18% |
| Jan. 12, 2026 | Mineralys Therapeutics, Inc. | $MLYS | Congleton Jon | Chief Executive Officer | S | Common Stock | 9119 | $32.21 | 646,268.0000 | 79,139,956 | 1.39% | 0.01% |
| Jan. 12, 2026 | Mineralys Therapeutics, Inc. | $MLYS | Congleton Jon | Chief Executive Officer | S | Common Stock | 7117 | $33.15 | 639,151.0000 | 79,139,956 | 1.10% | 0.01% |
| Nov. 21, 2025 | Mineralys Therapeutics, Inc. | $MLYS | Congleton Jon | Chief Executive Officer | M | Stock Option | 24082 | $0.00 | 0.0000 | 79,139,956 | 100.00% | 0.03% |
| Nov. 21, 2025 | Mineralys Therapeutics, Inc. | $MLYS | Congleton Jon | Chief Executive Officer | M | Common Stock | 24082 | $0.54 | 655,387.0000 | 79,139,956 | 3.81% | 0.03% |
| Nov. 11, 2025 | Mineralys Therapeutics, Inc. | $MLYS | Congleton Jon | Chief Executive Officer | S | Common Stock | 29207 | $45.20 | 776,430.0000 | 79,139,956 | 3.63% | 0.04% |
| Nov. 11, 2025 | Mineralys Therapeutics, Inc. | $MLYS | Congleton Jon | Chief Executive Officer | S | Common Stock | 12806 | $41.64 | 818,499.0000 | 79,139,956 | 1.54% | 0.02% |
| Nov. 11, 2025 | Mineralys Therapeutics, Inc. | $MLYS | Congleton Jon | Chief Executive Officer | S | Common Stock | 8862 | $42.31 | 809,637.0000 | 79,139,956 | 1.08% | 0.01% |
| Nov. 11, 2025 | Mineralys Therapeutics, Inc. | $MLYS | Congleton Jon | Chief Executive Officer | S | Common Stock | 4000 | $43.50 | 805,637.0000 | 79,139,956 | 0.49% | 0.01% |
| Nov. 11, 2025 | Mineralys Therapeutics, Inc. | $MLYS | Congleton Jon | Chief Executive Officer | S | Common Stock | 112275 | $45.83 | 664,155.0000 | 79,139,956 | 14.46% | 0.14% |
| Nov. 11, 2025 | Mineralys Therapeutics, Inc. | $MLYS | Congleton Jon | Chief Executive Officer | S | Common Stock | 32850 | $46.89 | 631,305.0000 | 79,139,956 | 4.95% | 0.04% |
| Oct. 13, 2025 | Mineralys Therapeutics, Inc. | $MLYS | Congleton Jon | Chief Executive Officer | S | Common Stock | 13548 | $42.63 | 832,857.0000 | 49,835,637 | 1.60% | 0.03% |
| Oct. 13, 2025 | Mineralys Therapeutics, Inc. | $MLYS | Congleton Jon | Chief Executive Officer | S | Common Stock | 1552 | $43.03 | 831,305.0000 | 49,835,637 | 0.19% | 0.00% |
| July 11, 2025 | Mineralys Therapeutics, Inc. | $MLYS | Congleton Jon | Chief Executive Officer | S | Common Stock | 15884 | $14.51 | 846,405.0000 | 49,835,637 | 1.84% | 0.03% |
| April 11, 2025 | Mineralys Therapeutics, Inc. | $MLYS | Congleton Jon | Chief Executive Officer | S | Common Stock | 15319 | $12.19 | 862,289.0000 | 49,835,637 | 1.75% | 0.03% |
| Feb. 13, 2025 | Mineralys Therapeutics, Inc. | $MLYS | Congleton Jon | Chief Executive Officer | A | Stock Option | 570000 | $0.00 | 570,000.0000 | 49,835,637 | 9999.99% | 1.14% |
| Jan. 13, 2025 | Mineralys Therapeutics, Inc. | $MLYS | Congleton Jon | Chief Executive Officer | S | Common Stock | 18333 | $9.06 | 877,608.0000 | 0 | 2.05% | 0.00% |
| Oct. 11, 2024 | Mineralys Therapeutics, Inc. | $MLYS | Congleton Jon | Chief Executive Officer | S | Common Stock | 15271 | $13.52 | 895,941.0000 | 0 | 1.68% | 0.00% |
| July 11, 2024 | Mineralys Therapeutics, Inc. | $MLYS | Congleton Jon | Chief Executive Officer | S | Common Stock | 15746 | $13.34 | 911,212.0000 | 0 | 1.70% | 0.00% |
| June 18, 2024 | Mineralys Therapeutics, Inc. | $MLYS | Congleton Jon | Chief Executive Officer | S | Common Stock | 16607 | $11.99 | 941,898.0000 | 0 | 1.73% | 0.00% |
| June 20, 2024 | Mineralys Therapeutics, Inc. | $MLYS | Congleton Jon | Chief Executive Officer | S | Common Stock | 14940 | $11.73 | 926,958.0000 | 0 | 1.59% | 0.00% |
| June 17, 2024 | Mineralys Therapeutics, Inc. | $MLYS | Congleton Jon | Chief Executive Officer | S | Common Stock | 17766 | $12.25 | 958,505.0000 | 0 | 1.82% | 0.00% |
| June 12, 2024 | Mineralys Therapeutics, Inc. | $MLYS | Congleton Jon | Chief Executive Officer | S | Common Stock | 16607 | $12.77 | 1,032,461.0000 | 0 | 1.58% | 0.00% |
| June 13, 2024 | Mineralys Therapeutics, Inc. | $MLYS | Congleton Jon | Chief Executive Officer | S | Common Stock | 39961 | $12.74 | 992,500.0000 | 0 | 3.87% | 0.00% |
| June 14, 2024 | Mineralys Therapeutics, Inc. | $MLYS | Congleton Jon | Chief Executive Officer | S | Common Stock | 16229 | $12.52 | 976,271.0000 | 0 | 1.64% | 0.00% |
| Feb. 13, 2024 | Mineralys Therapeutics, Inc. | $MLYS | Congleton Jon | Chief Executive Officer | A | Stock Option | 425000 | $0.00 | 425,000.0000 | 0 | 9999.99% | 0.00% |
| Nov. 22, 2023 | Mineralys Therapeutics, Inc. | $MLYS | Congleton Jon | Chief Executive Officer | P | Common Stock | 4250 | $5.97 | 1,049,068.0000 | 0 | 0.41% | 0.00% |
| Sept. 6, 2023 | Mineralys Therapeutics, Inc. | $MLYS | Congleton Jon | Chief Executive Officer | P | Common Stock | 2250 | $12.08 | 1,044,818.0000 | 0 | 0.22% | 0.00% |
| Aug. 17, 2023 | Mineralys Therapeutics, Inc. | $MLYS | Congleton Jon | Chief Executive Officer | P | Common Stock | 2250 | $12.10 | 1,042,568.0000 | 0 | 0.22% | 0.00% |
| Aug. 11, 2023 | Mineralys Therapeutics, Inc. | $MLYS | Congleton Jon | Chief Executive Officer | P | Common Stock | 2000 | $12.89 | 1,040,318.0000 | 0 | 0.19% | 0.00% |
| March 17, 2023 | Mineralys Therapeutics, Inc. | $MLYS | Congleton Jon | Chief Executive Officer | A | Stock Option | 99800 | $0.00 | 99,800.0000 | 0 | 9999.99% | 0.00% |
| Feb. 9, 2023 | Mineralys Therapeutics, Inc. | $MLYS | Congleton Jon | Chief Executive Officer | A | Stock Option | 250046 | $0.00 | 250,046.0000 | 0 | 9999.99% | 0.00% |